Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Monday 18 March, 2013

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 2815A
GlaxoSmithKline PLC
18 March 2013
 



  

 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

 

Following a revaluation of the cash element of the notional investment held within the US Retirement Savings Plan (The Plan), which is notionally held in GSK American Depositary Shares (ADSs), the Administrators of the Plan notified GlaxoSmithKline plc and the under-mentioned Persons on 18 March 2013 of an increase in the notional allocation of ADSs on 15 March 2013 at a price of $45.30 per ADS:-

 

 

Director/PDMR

 

 

 

Number of ADSs

 

Connected Person

 

Number of ADSs

 

Dr M M Slaoui

 

 

20

 

Dr K Slaoui

 

30

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).

 

 

V A Whyte

Company Secretary

 

18 March 2013

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDVLFFXXFBBBX

a d v e r t i s e m e n t